'Does the govt have Rs 80,000 crore for Covid-19 vaccines?': SII's Adar Poonawalla...

A phase III trial of the vaccine candidate developed by Oxford University and British pharmaceutical company AstraZeneca is underway in India as part of a production and testing deal with Pune-based Serum Institute of India (SII).